Virginia |
54-1167364 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification
No.) |
11240 Waples Mill Road, Suite 400, Fairfax,VA |
22030 | |
(Address of principal executive offices) |
(Zip Code) |
Page Number | ||||
PART I. |
FINANCIAL INFORMATION |
|||
Item 1. |
Financial Statements (Unaudited) |
|||
3 | ||||
4 | ||||
5 | ||||
6 | ||||
7 | ||||
Item 2. |
7 | |||
Item 3. |
11 | |||
PART II. |
OTHER INFORMATION |
|||
Item 6. |
11 | |||
11 | ||||
Annex A. |
12 | |||
Annex B. |
14 |
September 30, 2002 |
December 31, 2001 |
|||||||
Unaudited |
Audited |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
104,747 |
|
$ |
102,640 |
| ||
Accounts receivable, net |
|
971,261 |
|
|
1,526,372 |
| ||
Prepaid expenses |
|
56,340 |
|
|
22,255 |
| ||
Note receivable |
|
75,000 |
|
|
75,000 |
| ||
Other receivables |
|
52,238 |
|
|
22,203 |
| ||
|
|
|
|
|
| |||
Total current assets |
|
1,259,586 |
|
|
1,748,470 |
| ||
Fixed assets, net |
|
36,227 |
|
|
34,654 |
| ||
Capitalized software, net |
|
166,893 |
|
|
292,065 |
| ||
Other receivables |
|
11,865 |
|
|
31,865 |
| ||
Other assets |
|
58,275 |
|
|
58,275 |
| ||
|
|
|
|
|
| |||
Total assets |
$ |
1,532,846 |
|
$ |
2,165,329 |
| ||
|
|
|
|
|
| |||
LIABILITIES & STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Revolving line of credit |
$ |
402,100 |
|
$ |
596,000 |
| ||
Accounts payable |
|
636,572 |
|
|
1,024,717 |
| ||
Accrued payroll and related liabilities |
|
258,397 |
|
|
294,489 |
| ||
Other accrued liabilities |
|
97,973 |
|
|
175,158 |
| ||
Deferred revenue |
|
76,680 |
|
|
157,882 |
| ||
|
|
|
|
|
| |||
Total current liabilities |
|
1,471,722 |
|
|
2,248,246 |
| ||
Long-term liabilities: |
||||||||
Notes payable |
|
125,001 |
|
|
125,001 |
| ||
|
|
|
|
|
| |||
Total liabilities |
|
1,596,723 |
|
|
2,373,247 |
| ||
|
|
|
|
|
| |||
Stockholders equity: |
||||||||
Common stock, par value $0.01, 30,000,000 shares authorized; 11,788,126 shares issued, 10,283,515 outstanding at
September 30, 2002 and December 31, 2001 |
|
117,881 |
|
|
117,881 |
| ||
Additional paid in capital |
|
14,122,019 |
|
|
14,122,019 |
| ||
Retained earnings |
|
(13,449,464 |
) |
|
(13,593,505 |
) | ||
Less treasury stock, 1,504,611 shares at cost |
|
(854,313 |
) |
|
(854,313 |
) | ||
|
|
|
|
|
| |||
Total stockholders equity |
|
(63,877 |
) |
|
(207,918 |
) | ||
|
|
|
|
|
| |||
Total liabilities and stockholders equity |
$ |
1,532,846 |
|
$ |
2,165,329 |
| ||
|
|
|
|
|
|
For the three months ended |
||||||||
September 30, |
||||||||
2002 |
2001 |
|||||||
Unaudited |
Unaudited |
|||||||
Sales |
||||||||
Professional fees |
$ |
943,801 |
|
$ |
1,456,079 |
| ||
Software sales |
|
280,078 |
|
|
94,999 |
| ||
|
|
|
|
|
| |||
Total sales |
|
1,223,879 |
|
|
1,551,078 |
| ||
Cost of sales |
||||||||
Cost of professional fees |
|
705,299 |
|
|
983,769 |
| ||
Cost of software sales |
|
134,034 |
|
|
101,989 |
| ||
|
|
|
|
|
| |||
Total cost of sales |
|
839,333 |
|
|
1,085,758 |
| ||
|
|
|
|
|
| |||
Gross profit |
|
384,546 |
|
|
465,320 |
| ||
Selling, general and administrative expenses |
|
405,923 |
|
|
592,638 |
| ||
|
|
|
|
|
| |||
Income (loss) from operations |
|
(21,377 |
) |
|
(127,318 |
) | ||
Other (expenses) income, net |
|
(8,424 |
) |
|
1,267 |
| ||
|
|
|
|
|
| |||
Loss before provision for income taxes |
|
(29,801 |
) |
|
(126,051 |
) | ||
Provision for income taxes |
|
|
|
|
|
| ||
|
|
|
|
|
| |||
Net loss before extraordinary item |
|
(29,801 |
) |
|
(126,051 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
|
|
|
107,883 |
| ||
|
|
|
|
|
| |||
Net loss |
|
(29,801 |
) |
|
(18,168 |
) | ||
|
|
|
|
|
| |||
Earnings per common share: |
||||||||
Basic: |
||||||||
Net income (loss) before extraordinary Item |
$ |
0.00 |
|
$ |
(0.01 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
0.00 |
|
|
0.01 |
| ||
|
|
|
|
|
| |||
Net income (loss) |
$ |
0.00 |
|
$ |
0.00 |
| ||
|
|
|
|
|
| |||
Diluted: |
||||||||
Net income (loss) before extraordinary Item |
$ |
0.00 |
|
$ |
(0.01 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
0.00 |
|
|
0.01 |
| ||
|
|
|
|
|
| |||
Net income (loss) |
$ |
0.00 |
|
$ |
0.00 |
| ||
|
|
|
|
|
| |||
Weighted average common shares outstanding: |
||||||||
Basic |
|
10,283,515 |
|
|
10,087,925 |
| ||
Diluted |
|
10,283,515 |
|
|
10,087,925 |
|
For the nine months ended |
||||||||
September 30, |
||||||||
2002 |
2001 |
|||||||
Unaudited |
Unaudited |
|||||||
Sales |
||||||||
Professional fees |
$ |
4,301,275 |
|
$ |
3,700,823 |
| ||
Software sales |
|
535,784 |
|
|
347,712 |
| ||
|
|
|
|
|
| |||
Total sales |
|
4,837,059 |
|
|
4,048,535 |
| ||
Cost of sales |
||||||||
Cost of professional fees |
|
2,978,671 |
|
|
2,639,509 |
| ||
Cost of software sales |
|
346,347 |
|
|
405,306 |
| ||
|
|
|
|
|
| |||
Total cost of sales |
|
3,325,018 |
|
|
3,044,815 |
| ||
|
|
|
|
|
| |||
Gross profit |
|
1,512,041 |
|
|
1,003,720 |
| ||
Selling, general and administrative expenses |
|
1,354,813 |
|
|
1,282,539 |
| ||
|
|
|
|
|
| |||
Income (loss) from operations |
|
157,228 |
|
|
(278,819 |
) | ||
Other expenses, net |
|
(13,187 |
) |
|
(22,339 |
) | ||
|
|
|
|
|
| |||
Income (loss) before provision for income taxes |
|
144,041 |
|
|
(301,158 |
) | ||
Provision for income taxes |
|
|
|
|
|
| ||
|
|
|
|
|
| |||
Net income (loss) before extraordinary item |
|
144,041 |
|
|
(301,158 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
|
|
|
228,478 |
| ||
|
|
|
|
|
| |||
Net income (loss) |
|
144,041 |
|
|
(72,680 |
) | ||
|
|
|
|
|
| |||
Earnings per common share: |
||||||||
Basic: |
||||||||
Net Income (loss) before extraordinary Item |
$ |
0.01 |
|
$ |
(0.03 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
0.00 |
|
|
0.02 |
| ||
|
|
|
|
|
| |||
Net income (loss) |
$ |
0.01 |
|
$ |
(0.01 |
) | ||
|
|
|
|
|
| |||
Diluted: |
||||||||
Net Income (loss) before extraordinary Item |
$ |
0.01 |
|
$ |
(0.03 |
) | ||
Extraordinary gain - settlement of debt with equity |
|
0.00 |
|
|
0.02 |
| ||
|
|
|
|
|
| |||
Net income (loss) |
$ |
0.01 |
|
$ |
(0.01 |
) | ||
|
|
|
|
|
| |||
Weighted average common shares outstanding: |
||||||||
Basic |
|
10,283,515 |
|
|
9,865,056 |
| ||
Diluted |
|
10,923,312 |
|
|
9,865,056 |
|
For the nine months ended |
||||||||
September 30, |
||||||||
2002 |
2001 |
|||||||
Unaudited |
Unaudited |
|||||||
Net income (loss) |
$ |
144,041 |
|
$ |
(72,680 |
) | ||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Extraordinary gain |
|
|
|
|
(228,478 |
) | ||
Depreciation |
|
28,800 |
|
|
60,991 |
| ||
Amortization of capitalized software |
|
125,172 |
|
|
157,763 |
| ||
Gain on sale of fixed assets |
|
(3,710 |
) |
|
(9,353 |
) | ||
Changes in operating assets and liabilities |
||||||||
Accounts receivable |
|
555,111 |
|
|
(299,773 |
) | ||
Other receivables and prepaid expenses |
|
(44,120 |
) |
|
110,663 |
| ||
Accounts payable and accrued expenses |
|
(501,422 |
) |
|
143,186 |
| ||
Deferred revenue |
|
(81,202 |
) |
|
|
| ||
|
|
|
|
|
| |||
Net cash provided by operating activities |
|
222,670 |
|
|
(137,681 |
) | ||
|
|
|
|
|
| |||
Cash flows from investing activities |
||||||||
Purchases of fixed assets |
|
(30,373 |
) |
|
|
| ||
Proceeds from sale of fixed assets |
|
3,710 |
|
|
9,364 |
| ||
|
|
|
|
|
| |||
Net cash (used) provided by investing activities |
|
(26,663 |
) |
|
9,364 |
| ||
Cash flows from financing activities |
||||||||
Net (payments) borrowings under bank revolving line of credit |
|
(193,900 |
) |
|
10,409 |
| ||
Net proceeds from issuance of notes payable |
|
|
|
|
70,000 |
| ||
|
|
|
|
|
| |||
Net cash used by financing activities |
|
(193,900 |
) |
|
80,409 |
| ||
|
|
|
|
|
| |||
Net increase (decrease) in cash and cash equivalents |
|
2,107 |
|
|
(47,908 |
) | ||
Cash and cash equivalents at beginning of the period |
|
102,640 |
|
|
42,881 |
| ||
|
|
|
|
|
| |||
Cash and cash equivalents at end of the period |
$ |
104,747 |
|
$ |
(5,027 |
) | ||
|
|
|
|
|
| |||
Supplemental cash flow Information |
||||||||
Interest paid |
$ |
41,902 |
|
$ |
37,566 |
| ||
|
|
|
|
|
| |||
Non-cash financing activity: |
||||||||
Issuance of common stock to settle debt |
$ |
|
|
$ |
193,362 |
| ||
|
|
|
|
|
| |||
Non-cash operating activity: |
||||||||
Reduction of accounts payable through issuance of equity |
$ |
|
|
$ |
421,840 |
| ||
|
|
|
|
|
|
Income Before Extraordinary Item |
Extraordinary Item |
Net Income |
Shares |
Per Share Amount |
||||||||||||
Basic net loss per common share for the three months ended September 30, 2002: |
||||||||||||||||
Income available to common stockholders |
$ |
(29,801 |
) |
|
$ |
(29,801 |
) |
10,283,515 |
$ |
0.00 |
| |||||
Effect of dilutive stock options, warrants, and convertible notes |
|
|
|
|
|
|
|
|
|
|
| |||||
Diluted net loss per common share for the three months ended September 30, 2002: |
$ |
(29,801 |
) |
|
$ |
29,801 |
) |
10,283,515 |
$ |
0.00 |
| |||||
Basic net loss per common share for the three months ended September 30, 2001: |
||||||||||||||||
Income available to common stockholders |
$ |
(126,051 |
) |
107,883 |
$ |
(18,168 |
) |
10,087,925 |
$ |
0.00 |
| |||||
Effect of dilutive stock options, warrants, and convertible notes |
|
|
|
|
|
|
|
|
|
|
| |||||
Diluted net loss per common share for the three months ended September 30, 2001: |
$ |
(126,051 |
) |
107,883 |
$ |
(18,168 |
) |
10,087,925 |
$ |
0.00 |
| |||||
Basic net income per common share for the nine months ended September 30, 2002: |
||||||||||||||||
Income available to common stockholders |
$ |
144,041 |
|
|
$ |
144,041 |
|
10,283,515 |
$ |
0.01 |
| |||||
Effect of dilutive stock options |
|
|
|
|
|
|
|
38,854 |
|
|
| |||||
Effect of dilutive warrants |
|
|
|
|
|
|
|
100,943 |
|
|
| |||||
Effect of dilutive convertible notes |
|
11,250 |
|
|
|
11,250 |
|
500,000 |
|
|
| |||||
Diluted net income per common share for the nine months ended September 30, 2002: |
$ |
155,291 |
|
|
$ |
155,291 |
|
10,923,312 |
$ |
0.01 |
| |||||
Basic net loss per common share for the nine months ended September 30, 2001: |
||||||||||||||||
Income available to common stockholders |
$ |
(301,158 |
) |
228,478 |
$ |
(72,680 |
) |
9,865,056 |
$ |
(0.01 |
) | |||||
Effect of dilutive stock options, warrants, and convertible notes |
|
|
|
|
|
|
|
|
|
|
| |||||
Diluted net loss per common share for the nine months ended September 30, 2001: |
$ |
(301,158 |
) |
228,478 |
$ |
(72,680 |
) |
9,865,056 |
$ |
(0.01 |
) |
Information Analysis Incorporated (Registrant) |
||||||
Date: |
November 13, 2002 |
By: |
/S/ Sandor Rosenberg | |||
Sandor Rosenberg, Chairman of the Board and President | ||||||
By: |
/S/ Richard S. DeRose | |||||
Richard S. DeRose, Executive Vice President, Treasurer, and Chief Financial Officer |
1. |
I have reviewed this quarterly report on Form 10-QSB of Information Analysis Incorporated; |
2. |
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. |
Based on my knowledge, the financial statements, and other information included in this quarterly report, fairly present in all material respects the financial
condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. |
The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange
Act Rules 13a-14 and 15d-14) for the registrant and have: |
a) |
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) |
evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly
report (the Evaluation Date); and |
c) |
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date; |
5. |
The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit
committee of registrants board of directors (or persons performing the equivalent functions): |
a) |
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process,
summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
|
6. |
The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
|
Date: |
November 13, 2002 |
By: |
/S/ Sandor Rosenberg | |||
Sandor Rosenberg, Chairman of the Board and President |
1. |
I have reviewed this quarterly report on Form 10-QSB of Information Analysis Incorporated; |
2. |
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. |
Based on my knowledge, the financial statements, and other information included in this quarterly report, fairly present in all material respects the financial
condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. |
The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange
Act Rules 13a-14 and 15d-14) for the registrant and have: |
a) |
designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
b) |
evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly
report (the Evaluation Date); and |
c) |
presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the
Evaluation Date; |
5. |
The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit
committee of registrants board of directors (or persons performing the equivalent functions): |
a) |
all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process,
summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and |
b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
|
6. |
The registrants other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
|
Date: |
November 13, 2002 |
By: |
/S/ Richard S. DeRose | |||
Richard S. DeRose, Executive Vice President, Treasurer, and Chief
Financial Officer |
Annex B. |
Date: |
November 13, 2002 |
By: |
/S/ Sandor Rosenberg | |||
Sandor Rosenberg, Chairman of the Board and President |
Date: |
November 13, 2002 |
By: |
/S/ Richard S. DeRose | |||
Richard S. DeRose, Executive Vice President, Treasurer, and Chief
Financial Officer |